Results 231 to 240 of about 28,484 (289)

‘Case of the Month’ from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus

open access: yes
BJU International, EarlyView.
James P. Blackmur   +10 more
wiley   +1 more source

Bladder EpiCheck clinical utility to predict BCG response in non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To evaluate the performance of Bladder Epicheck® (BE; Nucleix Ltd., Rehovot, Israel) in predicting tumour recurrence and bacillus Calmette–Guérin (BCG) failure during the first year after induction treatment. Patients and methods Prospective study including 65 patients with non‐muscle‐invasive bladder cancer treated with BCG between 2018 and ...
Fiorella L. Roldán   +11 more
wiley   +1 more source

Saudi urologists' treatment pattern for high-risk <i>Bacillus</i> Calmette-Guérin naïve and <i>Bacillus</i> Calmette-Guérin unresponsive nonmuscle invasive bladder cancer. [PDF]

open access: yesUrol Ann
Alghafees M   +10 more
europepmc   +1 more source

External validation of current quality care metrics after radical nephroureterectomy

open access: yesBJU International, EarlyView.
Objectives To externally validate the tetrafecta and pentafecta frameworks for assessing the quality of radical nephroureterectomy (RNU) and their correlation with oncological outcomes in patients with localised upper tract urothelial carcinoma (UTUC).
Igor Duquesne   +20 more
wiley   +1 more source

New Insights into Upper Tract Urothelial Carcinoma: Lessons Learned from the ROBUUST Collaborative Study. [PDF]

open access: yesCancers (Basel)
Biasatti A   +36 more
europepmc   +1 more source

Perioperative complications of focal therapy for prostate cancer: results from the GeRmAn Nationwide inpatient Data (GRAND) study

open access: yesBJU International, EarlyView.
Objective To compare the perioperative complications of the most common focal therapy (FT) modalities for prostate cancer. Patients and Methods We assessed the GeRmAn Nationwide inpatient Data (GRAND) from 2005 to 2023, provided by the Research Data Center of the Federal Bureau of Statistics. We compared perioperative outcomes of high‐intensity focused
Nikolaos Pyrgidis   +9 more
wiley   +1 more source

Current application of blockchain technology in healthcare and its potential roles in Urology

open access: yesBJU International, EarlyView.
Objective To assess the current uses of blockchain technology in surgery and explore potential applications in urology. Methods A systematic literature review and critical appraisal was performed. The PubMed database was searched for all relevant papers published in English, between 2003 and 2023, on blockchain and surgery, and urology.
Sulleyman Felemban   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy